[1] Panizzutti B, Gubert C, Schuh AL, Ferrari P, Bristot G, Fries GR, et al. Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker? Journal of affective disorders. 2015; 182,64-69. https://doi.org/10.1016/j.jad.2014.12.010
[2] Pfaffenseller B, Fries GR, Wollenhaupt-Aguiar B, Colpo GD, Stertz L, Panizzutti B, et al. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev. Neurother. 2013; 13,827–842. https://doi:10.1586/14737175.2013.811981
[3] Rybakowski JK, Remlinger-Molenda A, Czech-Kucharska A, Wojcicka M, Michalak M, Losy J. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. Journal of affective disorders. 2013; 146(2),286-289. https://doi.org/10.1016/j.jad.2012.07.019
[4] Scaini G, Barichello T, Fries GR, Kennon EA, Andrews T, Nix BR, et al. TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation. Neuropsychopharmacology. 2019; 44(7),1291-1299. https://doi.org/10.1038/s41386-018-0293-4
[5] Cyrino LAR, Delwing-de Lima D, Ullmann OM, Maia TP. Concepts of Neuroinflammation and Their Relationship with Impaired Mitochondrial Functions in Bipolar Disorder. Frontiers in Behavioral Neuroscience. 2021; 15. https://doi:10.3389/fnbeh.2021.609487
[6] McEwen BS, and Gianaros PJ. Stress and allostasis-induced brain plasticity. Annual review of medicine. 2011; 62,431-445. https://doi:10.1146/annurev-med-052209-100430
[7] Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. The British journal of psychiatry. 1978; 133(5),429- 435. https://doi:10.1192/bjp.133.5.429.
[8] Hamilton M. A rating scale for depression. Journal of neurology, neurosurgery, and psychiatry. 1960; 23(1),56. https://doi.org/10.1136 / jnnp.23.1.56.
[9] Noble PB, Cutts JH. Separation of blood leukocytes by Ficoll gradient. Can. Vet. J. 1967; 8,110–111. [PubMed: 6046425] PMID: 4966278.
[10] Alp PR, Newsholme EA, Zammit VA. Activities of citrate synthase and NAD+-linked and NADP+-linked isocitrate dehydrogenase in muscle from vertebrates and invertebrates. Biochemical Journal. 1976; 154(3), 689-700. https://doi.org/10.1042/bj1540689
[11] Fischer JC, Ruitenbeek W, Berden JA, Trijbels JF, Veerkamp JH, Stadhouders AM, et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clinica chimica acta. 1985; 153(1),23-36. https://doi.org/10.1016/0009-8981(85)90135-4
[12] Cassina A, and Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Archives of biochemistry and biophysics. 1996; 328(2), 309-316. https://doi.org/10.1006/abbi.1996.0178
[13] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 93(1): 265–275 https://doi.org/10.1016/S0021-9258(19)52451-6
[14] Kapczinski F, Dal-Pizzol F, Teixeira A, Magalhães PVS, Kauer-Sant’Anna M, Klamt F, et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol. Psychiatry. 2010; 15,784–786. https://doi:10.1038/mp.2009.112
[15] Kim HK, Chen W, Andreazza AC. The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder. Neural plasticity. 2015; https://doi.org/10.1155/2015/408136
[16] Kim HK, Andreazza AC, Elmi N, Chen W, Young LT. Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation. Journal of psychiatric research. 2016; 72,43-50. https://doi.org/10.1016/j.jpsychires.2015.10.015
[17] Olmez I, Ozyurt H. Reactive oxygen species and ischemic cerebrovascular disease. Neurochemistry international. 2012; 60(2), 208-212. https://doi.org/10.1016/j.neuint.2011.11.009
[18] De Sousa RT, Uno M, Zanetti MV, Shinjo SM, Busatto GF, Gattaz WF, et al. Leukocyte mitochondrial DNA copy number in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2014b; 48, 32-35. https://doi.org/10.1016/j.pnpbp.2013.09.002
[19] Valvassori SS, Bavaresco DV, Feier G, Cechinel-Recco K, Steckert AV, Varela RB, et al. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes. Psychiatry research, 2018; 264,192-201. https://doi.org/10.1016/j.psychres.2018.03.089
[20] Zuccoli GS, Saia-Cereda VM, Nascimento JM, Martins-de-Souza D. The energy metabolism dysfunction in psychiatric disorders postmortem brains: focus on proteomic evidence. Frontiers in neuroscience. 2017; 11,493. https://doi.org/10.3389/fnins.2017.00493
[21] Lazzarino G, Amorini AM, Signoretti S, Musumeci G, Lazzarino G, Caruso G, et al. Pyruvate dehydrogenase and tricarboxylic acid cycle enzymes are sensitive targets of traumatic brain injury induced metabolic derangement. Int. J. Mol. Sci. 2019; 20:5774. https://doi:10.3390/ijms20225774
[22] Prabakaran S, Swatton J, Ryan M, Huffaker SJ, Huang JT-J, Griffin JL, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry. 2004; 9,684–697. https://doi:10.1038/sj.mp.4001511
[23] De Sousa RT, Streck EL, Zanetti MV, Ferreira GK, Diniz BS, Brunoni AR, et al. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology. 2015a; 232(1), 245-250. https://doi.org/10.1007/s00213-014-3655-6
[24] De Sousa RT, Zarate Jr CA, Zanetti MV, Costa AC, Talib LL, Gattaz WF, et al. Oxidative stress in early stage bipolar disorder and the association with response to lithium. Journal of psychiatric research. 2014a; 50,36-41. https://doi.org/10.1016/j.jpsychires.2013.11.011a
[25] Feier G, Valvassori SS, Varela RB, Resende WR, Bavaresco DV, Morais MO, et al. Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine. Pharmacology Biochemistry and Behavior. 2013; 103(3), 589-596. https://doi.org/10.1016/j.pbb.2012.09.010
[26] Valvassori SS, Bavaresco DV, Budni J, Bobsin TS, Gonçalves CL, de Freitas KV, et al. Effects of tamoxifen on tricarboxylic acid cycle enzymes in the brain of rats submitted to an animal model of mania induced by amphetamine. Psychiatry Res. 2014; 215,483–487. https://10.1016/j.psychres.2013.11.016
[27] Bubber P, Tang J, Haroutunian V, Xu H, Davis KL, Blass JP, et al. Mitochondrial enzymes in schizophrenia. J. Mol. Neurosci. 2004; 4, 315–321.https://doi:10.1385/JMN:24:2:315
[28] Bubber P, Hartounian V, Gibson GE, Blass, JP. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur. Neuropsychopharmacol. 2011; 21, 254–260. https://doi:10.1016/j.euroneuro.2010.10.007
[29] Yoshimi N, Futamura T, Kakumoto K, Salehi AM, Sellgren CM, Holmén-Larsson J, et al. Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle and amino acid metabolism in bipolar disorder. BBA Clin. 2016; 5,151–158. https://doi:10.1016/j.bbacli.2016.03.008
[30] Kato T, Iwamoto K. Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders. Neuropharmacology. 2014; 80,133–139. https://doi:10.1016/j.neuropharm.2013. 12.019
[31] Ben-Shachar D, and Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PloS one. 2008; 3(11), e3676. https://doi.org/10.1371/journal.pone.0003676
[32] Sun X, Wang JF, Tseng M, Young LT. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. Journal of psychiatry & neuroscience: JPN. 2006; 31(3),189–196. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1449880/pdf/20060500s00006p189.pdf
[33] Andreazza AC, Wang JF, Salmasi F, Shao L, Young LT. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. Journal of Neurochemistry. 2013; 127(4), 552-561. https://DOI10.1111/jnc.12316
[34] Steckert AV, Valvassori SS, Moretti M, Dal-Pizzol F, Quevedo J. Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochemical research. 2010; 35(9),1295-1301. https://doi.org/10.1007/s11064-010-0195-2
[35] Akarsu S, Torun D, Erdem M, Kozan S, Akar H, Uzun O. Mitochondrial complex I and III mRNA levels in bipolar disorder. Journal of affective disorders. 2015; 184, 160-163. https://DOI10.1016/j.jad.2015.05.060
[36] Rezin GT, Cardoso MR, Gonçalves L, Scaini G, Fraga DB, Riegel RE, et al., Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochemistry International. 2008; 53,395-400, https://doi.org/10.1016/j.neuint.2008.09.012 Geddes JR, and
[37] Gubert C, Stertz L, Pfaffenseller B, Panizzutti BS, Rezin GT, Massuda R, et al. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. Journal of psychiatric research. 2013; 47(10),1396-1402. https://doi.org/10.1016/j.jpsychires.2013.06.018
[38] Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, et al. Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder. Neuropsychiatric disease and treatment. 2019; 15,233. https://DOI10.2147/NDT.S188964
[39] Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Zvěřová M, et al. Mitochondrial dysfunction in blood platelets of patients with manic episode of bipolar disorder. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2019; 18(3),222-231. https://DOI10.2174/1871527318666181224130011
[40] Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Human molecular genetics. 2005; 14(2), 241-253. https://doi.org/10.1093/hmg/ddi022
[41] Bachmann RF, Wang Y, Yuan P, Zhou R, Li X, Alesci S, et al. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. International Journal of Neuropsychopharmacology. 2009; 12(6),805-822. https://doi.org/10.1017/S1461145708009802
[42] Maurer IC, Schippel P, Volz HP. Lithium‐induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar disorders. 2009; 11(5),515-522. https://doi.org/10.1111/j.1399-5618.2009.00729.x
[43] Corena-McLeod M, Walss-Bass C, Oliveros A, Gordillo-Villegas A, Ceballos C, Charlesworth CM, et al. New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations. PloS one. 2013; 8(5), e52147. https://doi.org/10.1371/journal.pone.0052147
[44] Geddes JR, and Miklowitz DJ. Treatment of bipolar disorder. Lancet (London, England). 2013; 381(9878),1672–1682. https://doi.org/10.1016/S0140-6736(13)60857-0
[45] Fritz K, Russell AM, Allwang C, Kuiper S, Lampe L, Malhi GS. Is a delay in the diagnosis of bipolar disorder inevitable? Bipolar disorders. 2017; 19(5),396-400.https://doi.org/10.1111/bdi.12499
[46] O'Donovan C and Alda M. Depression preceding diagnosis of bipolar disorder. Frontiers in psychiatry. 2020; 11, 500. https://doi.org/10.3389/fpsyt.2020.00500
[47] Marques AP, Resende R, Silva DF, Batista M, Pereira D, Wildenberg B, et al. Mitochondrial Alterations in Fibroblasts of Early Stage Bipolar Disorder Patients. Biomedicines. 2021; 9(5),522. https://doi.org/10.3390/biomedicines9050522